AURINIA PHARMACEUTICALS INC's ticker is AUPH and the CUSIP is 05156V102. A total of 168 filers reported holding AURINIA PHARMACEUTICALS INC in Q2 2021. The put-call ratio across all filers is 1.25 and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2022 | $262,000 | -45.2% | 34,838 | -26.9% | 0.01% | -40.0% |
Q2 2022 | $478,000 | -16.7% | 47,638 | +2.8% | 0.02% | -4.8% |
Q1 2022 | $574,000 | -84.0% | 46,338 | -70.4% | 0.02% | -83.5% |
Q4 2021 | $3,578,000 | -27.0% | 156,458 | -29.4% | 0.13% | -39.2% |
Q3 2021 | $4,904,000 | +272.9% | 221,633 | +118.5% | 0.21% | +287.0% |
Q2 2021 | $1,315,000 | -7.5% | 101,433 | -7.3% | 0.05% | -8.5% |
Q1 2021 | $1,422,000 | -35.5% | 109,420 | -31.4% | 0.06% | -30.6% |
Q4 2020 | $2,205,000 | -8.8% | 159,441 | -2.8% | 0.08% | -26.1% |
Q3 2020 | $2,417,000 | +3.3% | 164,108 | +14.0% | 0.12% | -12.9% |
Q2 2020 | $2,340,000 | +218.4% | 143,958 | +184.4% | 0.13% | +127.6% |
Q1 2020 | $735,000 | -9.0% | 50,625 | +26.8% | 0.06% | +28.9% |
Q4 2019 | $808,000 | – | 39,922 | – | 0.04% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Blackcrane Capital, LLC | 503,248 | $6,535,000 | 10.30% |
Prosight Management, LP | 360,834 | $4,685,000 | 3.84% |
Healthcare Value Capital, LLC | 100,000 | $1,299,000 | 2.89% |
KINGDON CAPITAL MANAGEMENT, L.L.C. | 1,748,208 | $22,700,000 | 2.32% |
DG Capital Management, LLC | 591,154 | $7,676,000 | 1.83% |
NEA Management Company, LLC | 5,172,683 | $67,193,000 | 1.51% |
Altium Capital Management LP | 408,908 | $5,310,000 | 1.47% |
IRONWOOD INVESTMENT MANAGEMENT LLC | 170,316 | $2,212,000 | 1.17% |
INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 298,500 | $3,875,000 | 1.02% |
KNOTT DAVID M | 154,840 | $2,011,000 | 0.86% |